Drug Type Small molecule drug |
Synonyms 쏠리니액 |
Target |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (25 Jul 2024), |
Regulation- |
Molecular FormulaC8H11NO3 |
InChIKeyLXNHXLLTXMVWPM-UHFFFAOYSA-N |
CAS Registry65-23-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Motion Sickness | KR | 25 Jul 2024 |